419 related articles for article (PubMed ID: 8993032)
1. Genomic footprinting of retinoic acid regulated promoters in embryonal carcinoma cells.
Dey A; Ozato K
Methods; 1997 Feb; 11(2):197-204. PubMed ID: 8993032
[TBL] [Abstract][Full Text] [Related]
2. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM
Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D3- and retinoic acid-induced monocytic differentiation: interactions between the endogenous vitamin D3 receptor, retinoic acid receptors, and retinoid X receptors in U-937 cells.
Botling J; Oberg F; Törmä H; Tuohimaa P; Bläuer M; Nilsson K
Cell Growth Differ; 1996 Sep; 7(9):1239-49. PubMed ID: 8877104
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the factors involved in the retinoic acid-induced differentiation of a retinoid-hypersensitive embryonal carcinoma cell mutant.
Dietrich JM; McCormick PJ
Exp Cell Res; 1994 Feb; 210(2):201-8. PubMed ID: 8299717
[TBL] [Abstract][Full Text] [Related]
5. The promoter context is a decisive factor in establishing selective responsiveness to nuclear class II receptors.
Sanguedolce MV; Leblanc BP; Betz JL; Stunnenberg HG
EMBO J; 1997 May; 16(10):2861-73. PubMed ID: 9184230
[TBL] [Abstract][Full Text] [Related]
6. A dynamic balance between ARP-1/COUP-TFII, EAR-3/COUP-TFI, and retinoic acid receptor:retinoid X receptor heterodimers regulates Oct-3/4 expression in embryonal carcinoma cells.
Ben-Shushan E; Sharir H; Pikarsky E; Bergman Y
Mol Cell Biol; 1995 Feb; 15(2):1034-48. PubMed ID: 7823919
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid-mediated down-regulation of Oct3/4 coincides with the loss of promoter occupancy in vivo.
Minucci S; Botquin V; Yeom YI; Dey A; Sylvester I; Zand DJ; Ohbo K; Ozato K; Scholer HR
EMBO J; 1996 Feb; 15(4):888-99. PubMed ID: 8631309
[TBL] [Abstract][Full Text] [Related]
8. Different response to retinoic acid of two teratocarcinoma cell lines.
Wan YJ; Wang L; Wu TC
Exp Cell Res; 1995 Aug; 219(2):392-8. PubMed ID: 7543852
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous retinoic acid receptor beta 2 expression during mesoderm differentiation of P19 murine embryonal carcinoma cells.
Pratt MA; Crippen CA; Ménard M
Differentiation; 2000 May; 65(5):271-9. PubMed ID: 10929206
[TBL] [Abstract][Full Text] [Related]
10. Derivation and characterization of retinoid-resistant human embryonal carcinoma cells.
Moasser MM; Khoo KS; Maerz WJ; Zelenetz A; Dmitrovsky E
Differentiation; 1996 Jul; 60(4):251-7. PubMed ID: 8765055
[TBL] [Abstract][Full Text] [Related]
11. [Genetic control of the development by retinoic acid].
Mark M; Kastner P; Ghyselinck NB; Krezel W; Dupé V; Chambon P
C R Seances Soc Biol Fil; 1997; 191(1):77-90. PubMed ID: 9181129
[TBL] [Abstract][Full Text] [Related]
12. A specific defect in the retinoic acid response associated with human lung cancer cell lines.
Zhang XK; Liu Y; Lee MO; Pfahl M
Cancer Res; 1994 Nov; 54(21):5663-9. PubMed ID: 7923214
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of retinoic acid receptor beta in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells.
Swisshelm K; Ryan K; Lee X; Tsou HC; Peacocke M; Sager R
Cell Growth Differ; 1994 Feb; 5(2):133-41. PubMed ID: 8180126
[TBL] [Abstract][Full Text] [Related]
14. Expression of retinoic acid receptor beta is associated with inhibition of keratinization in human head and neck squamous carcinoma cells.
Zou CP; Hong WK; Lotan R
Differentiation; 1999 Jan; 64(2):123-32. PubMed ID: 10234809
[TBL] [Abstract][Full Text] [Related]
15. Dominant negative retinoid X receptor beta inhibits retinoic acid-responsive gene regulation in embryonal carcinoma cells.
Minucci S; Zand DJ; Dey A; Marks MS; Nagata T; Grippo JF; Ozato K
Mol Cell Biol; 1994 Jan; 14(1):360-72. PubMed ID: 8264603
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of ligand induced promoter occupancy in vivo by a dominant negative RXR.
Blanco JC; Dey A; Leid M; Minucci S; Park BK; Jurutka PW; Haussler MR; Ozato K
Genes Cells; 1996 Feb; 1(2):209-21. PubMed ID: 9140065
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid upregulates cone arrestin expression in retinoblastoma cells through a Cis element in the distal promoter region.
Li A; Zhu X; Craft CM
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1375-83. PubMed ID: 11980849
[TBL] [Abstract][Full Text] [Related]
18. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
[TBL] [Abstract][Full Text] [Related]
19. Ligand-dependent occupancy of the retinoic acid receptor beta 2 promoter in vivo.
Dey A; Minucci S; Ozato K
Mol Cell Biol; 1994 Dec; 14(12):8191-201. PubMed ID: 7969156
[TBL] [Abstract][Full Text] [Related]
20. Utilization of DR1 as true RARE in regulating the Ssm, a novel retinoic acid-target gene in the mouse testis.
Han K; Song H; Moon I; Augustin R; Moley K; Rogers M; Lim H
J Endocrinol; 2007 Mar; 192(3):539-51. PubMed ID: 17332523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
